BiondVax signs definitive collaboration agreement for the development of a pipeline of innovative nanosized antibody (NanoAb) therapies
/PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative...
Israel General Florian Beilhack Martin Stratmann Joshuae Phillipson Matthias Dobbelstein Amir Reichman
Source: prnewswire.com